Featured Stories
Smokers More Vulnerable to Joint Replacement Failures

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Study Finds Plavix May Only Benefit Smokers

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher’s Financial Ties to Takeda

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Motion to Consolidate Xarelto Bleeding Side Effects Cases in Multidistrict Litigation

Plaintiffs who allege they were injured by the blood thinner Xarelto have filed a motion to have their cases consolidated as part of a multidistrict litigation (MDL).

At least 21 actions pending in 10 judicial districts make similar allegations against the manufacturers of Xarelto (rivaroxaban), a medicine prescribed to prevent or treat blood clots and reduce the risk of stroke. An MDL coordinates proceedings in complex litigation where a large number of lawsuits allege similar injuries associated with a medication or product. The motion requests the U.S. Joint Panel of Multidistrict Litigation (JPML) to assign the MDL to the Southern Illinois District, which handled the recent MDL involving another new anticoagulant, Pradaxa. Continue reading

Posted in Defective Products, Pharmaceuticals, Pradaxa |

Motion Filed to Consolidate Xarelto Lawsuits into MDL

The anticoagulant Xarelto has raised a number of safety concerns in the short time it has been on the market. A number of lawsuits have been filed alleging that Bayer hid the risks of the drug, including an increased risk of bleeding. Now, a motion has been filed to consolidate the lawsuits into a multidistrict litigation (MDL).

The U.S. Joint Panel of Multidistrict Litigation (JPML) should centralize cases in the Southern District Illinois court, the motion stated. Plaintiffs said that the court is an ideal venue because it has has experience with the recent MDL over Pradaxa, another new bloodthinner. In a hearing that will take place either late this year or early next year, the JPML will hear arguments on the motion. Continue reading

Posted in Legal News |

Toyota Recalls 1.67 Million Vehicles Worldwide

Toyota Motor Corp. has announced the recall of 1.67 million vehicles worldwide over safety defects, including faulty brakes and fuel components.

A Toyota representative said the company is not aware of any accidents or injuries related to the defects. The recall involves 1 million vehicles in Japan and 615,000 in other countries, Law360 reports. Fuel delivery pipe problems affect 759,000 vehicles and 802,000 others have brake issues. In addition, 190,000 Corolla Rumion and Auris models in Japan will be recalled because of faulty emission control components. All of the recalled vehicles in the United States are Lexus sedans with potentially leaky fuel pipes, which could cause the cars to catch fire, the Toyota representative said. Continue reading

Posted in Defective Products, Motor Vehicles, Product Recalls, Recalled Vehicles, Toyota Recall |

Study: Significant Number of Medication Errors Occur in Young Children

According to a study published in the journal Pediatrics, medication mistakes among young children occur more frequently than some would imagine. The study, which was based on calls to poison control hotlines, found that a medication mistake occurred in a child roughly every eight minutes from 2002 through 2012. The authors state that medication mistakes can lead to injury and sometimes death, in addition to increasing healthcare spending.

Researchers saw an increase in the rate of reported medication errors during the 11-year time frame of the study. The exception to this was cough and cold medicines. Henry Spiller, an author of the study and director of the Central Ohio Poison Center at Nationwide Children’s Hospital in Columbus, told Reuters Health that this decrease was preceded by a multipronged campaign to reduce the use of these products in children. The findings suggest that education has been successful in this effort. “We think that multipronged effort had an effect,” said Spiller to Reuters Health. “We can see a drop associated with these efforts.” Continue reading

Posted in Legal News |

New Jersey Appeals Court Considering Facebook Ethics Case

A New Jersey appeals court is considering whether the Office of Attorney Ethics has the power to file ethics grievances against lawyers after district ethics committees have declined to do so, and whether the judges themselves even have the authority to get involved in the dispute.

If the panel decides that the Superior Courts can exercise jurisdiction over ethics matters, it will then have to decide whether OAE Director Charles Centinaro violated the rules governing the disciplinary process when he filed a complaint against two lawyers in Hackensack, after District II-B Ethics Committee secretary Doris Newman concluded their actions did not constitute unethical conduct, New Jersey Law Journal reports. Continue reading

Posted in Legal News |

Limited Data Available on Medication Dosage for Kids

When it comes to prescribing medication for children, there is often little data to support information about dosage, safety or efficiency. According to Scientific American, most clinical trials do not include children so the burden of deciding what treatments to use and how falls on physicians.

Scientific American reports that only 46 percent of drugs used in kids have been approved by the U.S. Food and Drug Administration (FDA) for pediatric use. In the past, that statistic was far worse. Continue reading

Posted in Legal News |

Trinity Industries Accused of Hiding Failed Crash Tests in Whistleblower Trial over Guardrails

In a trial over its guardrails, Trinity Industries was questioned about why they did not tell authorities about five failed crash tests. The New York Times reports that the case was filed under the False Claims Act by a competitor who alleged that the company violated federal rules when it failed to notify the Federal Highway Administration that it modified the design of its ET-Plus rail head in 2005.

These guardrails are the subject of the safety concerns outside of this federal lawsuits, according to The New York Times. Last month, the states of Missouri and Massachusetts banned the design and began their own investigations. Virginia also took issued with Trinity, and said in a letter that it believes the company failed to adequately test the ET-Plus. The state wants further testing. Continue reading

Posted in Legal News |

Jury Problems Not Enough to Reverse No-Cause Verdict

Despite indications that a jury might have misunderstood what evidence it was allowed to consider and that one juror called the plaintiff a liar in a discussion outside the jury room, an appeals court found there were not sufficient grounds to reverse the no-cause verdict.

The appeals court upheld the verdict and the trial judge’s denial of a request for either post-verdict questioning of the jurors or a new trial. The plaintiff had sued over whiplash injuries to her neck allegedly from a 2010 automobile accident, where her car was rear ended and her head slammed into the back of her seat, the New Jersey Law Journal reports. Continue reading

Posted in Accident, Legal News |

Class Action Lawsuit over Infuse Could Complicate Medtronic Acquisition of Covidien

A class action lawsuit over Medtronic’s bone growth product Infuse could complicate the company’s planned acquisition of Dublin-based device maker Covidien.

U.S. District Judge John Tunheim will allow lawyers for Medtronic investors to explore an alleged coverup of Infuse’s side effects by Medtronic officials, the Minneapolis Star Tribune reports. Off-label use of Infuse has allegedly injured thousands of patients. Tunheim said the plaintiffs could pursue their claim that former Medtronic CEO William Hawkins purposely made misstatements to stock analysts to hide the fact that the Food and Drug Administration (FDA) had refused to approve Amplify, the next iteration of Infuse. Continue reading

Posted in Class Action Lawsuits, Defective Medical Devices, Legal News, Medtronic Infuse |

Sugary Sodas may be Linked to Higher Risk of Rheumatoid Arthritis

According to a study recently published in The American Journal of Clinical Nutrition, women are more likely to develop rheumatoid arthritis (RA) if they drink one or more sugar-sweetened sodas a day compared those who drink less than one soda per month or less.

According to the Arthritis Today, RA leads to inflammation and subsequent joint pain and damage, fatigue and other consequences. It is a systemic, autoimmune disease believed to be caused by a combination of genetic and environmental factors. Continue reading

Posted in Legal News |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.